Cancer Research UK's Drug Development Office has opened the first trial of a new type of drug to treat children aged from six months to 18 years with acute leukaemia, who are no longer responding to treatment.
Creating memories for families by sharing information relating to children and parents with regard to activities, products, school, home and more.
Cancer Research UK opens first AT9283 trial to treat childhood leukaemia
- Login or register to post comments
- Feed: Pediatrics News Feed
- Original article